Boston Scientific’s HeartLogic™ platform uses AI to analyze multi-source patient data collected remotely via wearables and sensors, predicting heart failure decompensation up to 34 days in advance to enable early intervention and reduce hospitalizations.
- Early detection of decompensation up to 34 days ahead
- Proactive care enabled
- Reduced hospital visits and readmissions
Late detection of heart failure exacerbations led to increased hospitalizations
Deployed AI-powered remote patient monitoring platform integrating sensor data and predictive analytics
- Improved patient outcomes
- Reduced hospital admissions
- Enhanced chronic disease management
